Supplemental Experimental Procedures
The complete loss of eEF2 phosphorylation in Eef2k -/-mice.
To investigate the physiological role of eEF2K, we generated Eef2k -/-mice by disrupting the Eef2K gene in mouse embryonic stem cells. A targeting vector was used in which exon 7 and the majority of exon 8 of the Eef2K gene were replaced with the neomycin resistance gene ( Figure   S2A ). This strategy resulted in elimination of a portion of the catalytic domain of eEF2K
( Figure S2B ). The mouse genotypes were analyzed by the PCR reactions ( Figure S2C ). The Eef2 +/-mice produced progeny of Eef2 +/-, Eef2k +/+ and Eef2k -/-mice with the expected ratio of 2:1:1. We analyzed the phenotype of Eef2k -/-mice and found that they were overtly normal, fertile and had a normal growth rate, food intake, and glucose and insulin tolerance tests ( Figure   S2F -I). Western blotting showed that no eEF2K protein was detected and no phosphorylation of eEF2 was observed in cell extracts from Eef2k -/-mice ( Figure S2D ). We also performed a kinase assay using purified rabbit eEF2 as a substrate and found that purified eEF2 was unable to be phosphorylated in Eef2k -/-cell lysates, indicating a complete lack of eEF2K activity in Eef2k -/-mice ( Figure S2E ).
Cell viability assay
For the MTT assay, 3*10 3 cells/well (100 µl) were grown overnight in 96-well plates with DMEM containing 10% fetal bovine serum. Cells were treated with doxorubicin for 24 hr, then incubated with 20 µl of 1 mg/ml MTT (3-(4,5-dimethylthhiazol)-2,5-dipheyltetrazolium bromide) at 37°C for 4 hr. Medium was removed and DMSO was added into each well. The number of viable cells was determined by measuring the absorbance at 550 nm.
Caspase inhibition by QVD-Oph
Pan-caspase inhibitor QVD-Oph [quinoline-Val-Asp(OME)-CH 2 -PH] was purchased from
Calbiochem. When cells achieved a confluency of 70%, 20 µM QVD-Oph was added 30 min before the apoptotic stimuli. Consequently, cells were incubated in 1 µM doxorubicin (Sigma, MO) for 24 hr in the presence or absence of QVD-Oph to induce apoptosis. Cells were harvested and cell lysates were used for Western blotting analysis.
Analysis of mouse estrous cycle
Female mice were separated according to their genotypes. Vaginal smears were obtained every morning and stained with Giemsa stain (Sigma, MO). Light microscopy was used to identify the different stages of the estrous cycle based on smear cell morphologies. The approximate duration of each phase was estimated.
Hormone measurements
To measure hormone levels, estrus cycles were analyzed by vaginal smears in 3-month-old wildtype and eEF2K-deficient female mice. Mice were sacrificed on the estrus day and blood samples were collected by heart puncture. Whole blood samples were transferred into 1.5 mL centrifuge tubes and allowed to clot at room temperature for 90 min. Samples were centrifuged at 2,000g for 15 min, after which the serum was stored at -20°C. Mouse FSH-RIA, LH-IRMA, Progesterone-RIA, and Estradiol-ELISA assays were conducted by The University of Virginia
Center for Research in Reproduction Ligand Assay and Analysis Core Facilities

Glucose and insulin tolerance test
For glucose tolerance test, 2-month-old Eef2k +/+ and Eef2k -/-male mice were fasted overnight, and IP injected with 20 mg/ml glucose at a dose of 2 g/kg body weight. For insulin tolerance test, mice were starved for 5 hr and IP injected with 0.75 U/kg body weight recombinant insulin (Invitrogen, CA). Blood was obtained from the tail at time points 0, 15, 30, 60, 120 min for glucose measurement.
Kinase assay
The eEF2 kinase assay was performed as described . Mouse cell lysates were incubated with purified rabbit reticulocyte eEF2 in reaction buffer (50 mM Hepes−KOH with pH 6.6, 10 mM magnesium acetate, 5 mM DTT, 100 µM CaCl 2
